The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: RBS Confirms Dividend After US Settlement

Wed, 15th Aug 2018 07:44

LONDON (Alliance News) - Stocks in London are set to rebound on Wednesday, with focus on the latest inflation data from the UK, while Royal Bank of Scotland confirmed its first dividend payment since the financial crisis after reaching a final settlement with the US government.In other early UK company news, Admiral saw a rise in interim profit, Hikma said its half-year results exceeded expectations and thus lifted its annual guidance for two units, and Balfour Beatty boosted its interim payout by a third.IG says futures indicate the FTSE 100 index of large-caps to open 15.46 points higher at 7,627.10 on Wednesday. The FTSE 100 index closed closed down 0.4%, or 30.81 points at 7,611.64 on Tuesday.In focus in the UK on Wednesday is the latest consumer price index reading for July, due at 0930 BST and seen edging up to an annual inflation rate of 2.5% from 2.4% in June. This comes after wage data on Tuesday showed a slowing of growth in average earnings, rising just 2.4% on year in the three months to June, from 2.5% the previous month."In general, we believe the inflation prints will be interesting to follow in H2 18, as we believe the Bank of England is too optimistic on the inflation outlook," said Aila Mih, analyst at Danske Bank. Danske Bank sees UK CPI inflation slowing to 2.3% in July.Sterling was quoted at USD1.2715 early Wednesday ahead of the CPI data, down from USD1.2736 at the London equities close on Tuesday.Drugmaker GlaxoSmithKline said ViiV Healthcare - its HIV treatment joint venture - saw its Atlas study meet its primary endpoint.Phase 3 of the study - for a long-acting, injectable two-drug regimen for the treatment of HIV - showed long-acting cabotegravir and rilpivirine, injected once a month, had similar efficacy to a standard of care, daily, oral three-drug regimen at Week 48. The injectable treatment regimen met the primary endpoint for non-inferiority, Glaxo said. Overall safety, virologic response and drug resistance results for the injectable regimen were consistent with results from the phase II Latte and Latte-2 studies.Insurer Admiral posted a rise in half-year profit and lifted its interim payout, with growth in underwriting profit and a improved combined ratio.Pretax profit rose 9% to GBP211 million in the first half of the year from GBP193 million a year prior, as net revenue also increased 9% to GBP600 million from GBP550 million. The company lifted its interim dividend 7% to 60.0p per share - representing an ordinary payout of 40.8p and a special dividend of 19.2p - from 56.0p last year.Underwriting profit grew to GBP93.4 million from GBP88.9 million, while the group's combined ratio improved to 87.4% from 90.0% last year. A score under 100% indicates underwriting profitability."The European insurers delivered overall profitability whilst growing the business by almost a fifth in a year. But that's not the only important milestone in the first half, which was characterised by substantial growth across almost all our businesses. Most importantly, the core UK car insurance business continues to grow," said Chief Executive David Stevens.The US Justice Department late Tuesday said RBS will pay USD4.9 billion to settle civil claims for misleading investors in residential mortgage-backed securities prior to the financial crisis that began in 2008.This settlement had been agreed in principle back in May this year.RBS "routinely made misrepresentations to investors" who bought securities backed by risky mortgages and concealed their high risk of default, the Justice Department said. The activity cited by the department took place from 2005 to 2008.The penalty is the largest imposed on a single financial institution by the Justice Department for misconduct linked to the crisis.Ross McEwan, RBS chief executive, said in a statement that the state-backed lender is "pleased to have reached a final settlement" and the bank can now "focus our energy on serving our customers better and returning capital to our shareholders".As a result on Wednesday, RBS declared an interim dividend of 2p per share. The payout had been proposed at the time of the lender's interim results, earlier in August, but was conditional on a settlement with the DoJ.Hochschild Mining said revenue over the first half grew to USD372.3 million from USD340.8 million, as pretax profit remained broadly flat, coming in at USD38.6 million from USD38.9 million last year. The gold miner boosted its interim payout by 42% to 1.965 cents, from 1.38 cents a year ago.There was "record" production of 138,427 gold equivalent ounces at Inmaculada in the period, while "encouraging" results were delivered at Arcata. San Jose drilling is set to restart in September after poor seasonal weather conditions.The company said it is on track to deliver attributable production target of 38.0 million silver equivalent ounces for 2018, with all-in sustaining costs to be in line with USD13.0 to USD13.4 per silver equivalent ounce."Precious metal prices are currently nearing the bottom of their recent trading range. However, Hochschild's operational performance combined with a strong balance sheet, exciting early results from our brownfield programme, a significant recent devaluation in the Argentine peso and no current hedges in place leave us in a beneficial position," said Hochschild.Support services and construction firm Balfour Beatty said revenue for the first half fell to GBP3.84 billion from GBP4.20 billion, but pretax profit increased more than four-fold to GBP50 million from GBP12 million.While revenue fell, the company said, gross profit increased and overheads declined, resulting in improved profitability.Leo Quinn, chief executive, said: "All our businesses are now either achieving industry standard margins or on track to do so in the second half. The disciplines installed under Build to Last are also enabling us to increase the order book.""Given the strength of our balance sheet and the board's confidence that the group's full year earnings will meet expectations, we are raising the interim dividend by 33% and plan to repay the outstanding convertible bonds this year." The company raised its dividend to 1.6p from 1.2p.Hikma Pharmaceuticals said revenue rose 11% over the first half of the year, to USD989 million, as pretax profit climbed to USD141 million from USD100 million.Chief Executive Siggi Olafsson said he was "pleased" with the performance, which exceeded expectations, allowing the company to raise its guidance for both the Injectables and Generics businesses for the full-year."The measures we have taken and investments we have made across the Group over the past year are delivering results, but we still have work to do. Our markets are competitive and we don't expect the same demand for some of our injectable products to continue into 2019," Olafsson noted.Hikma now expects Injectables revenue to be between USD775 million to USD825 million, with Generics revenue to be between USD600 million to USD650 million.At the time of its annual results, released in March 2018, the company said Injectables revenue was to be between USD750 million to USD800 million, and Generics between USD550 million to USD600 million.In the US on Tuesday, Wall Street ended higher, with the Dow Jones Industrial Average ending up 0.5%, the S&P 500 up 0.6% and Nasdaq Composite closing 0.7% higher.Turkey increased tariffs on US-made products ranging from cars to tobacco on Wednesday in the midst of a currency crisis and a diplomatic and trade spat with the US.The new measures, published in the official gazette, go into effect immediately and include a 140% hike in US-made alcoholic beverages and an increase of 120% on US cars.On Tuesday, Erdogan called for a boycott of US electronic goods."If they have iPhone, we have Samsung on the other side," Erdogan told members of his Justice and Development Party referring to the South Korean company, which is Apple's main competitor in the smartphone market.The Turkish lira - which hit record lows at the beginning of the week, sparking contagion fears - recovered slightly against the dollar and euro on Tuesday, following reports that Finance Minister Beart Albayrak will brief hundreds of foreign investors in a teleconference on Thursday.The slump in the lira has seen foreign currency suppliers in the UK struggle to meet demand for the Turkish currency.Post Office Travel Money apologised to holidaymakers who have struggled to get hold of lira from some of its branches. Thomas Cook Money - which is supplied by Travelex - has also been running low on lira.In Asia on Wednesday, the Japanese Nikkei 225 index closed down 0.7%. In China, the Shanghai Composite is down 1.6%, while the Hang Seng index in Hong Kong is also down 1.6%.In the economic calendar on Wednesday, besides UK inflation data, are US MBA mortgage applications at 1200 BST with retail sales at 1330 BST and second quarter nonfarm productivity due at the same time.Markets in Italy are closed for the Assumption Day holiday, while markets in France and Germany will remain open as those countries observe the holiday.
More News
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.